UK markets open in 2 minutes
NIKKEI 225
39,103.22 +486.12 (+1.26%) HANG SENG
18,889.84 -305.76 (-1.59%) CRUDE OIL
77.29 -0.28 (-0.36%) GOLD FUTURES
2,367.20 -25.70 (-1.07%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,657.96 -206.67 (-0.38%)
BCRX Jun 2024 4.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:48AM EDT. Market open.
Loading interactive chart…
- GuruFocus.com
Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
- GuruFocus.com
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
- GuruFocus.com
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.
© 2024 Yahoo. All rights reserved.